已关闭
  • 文献求助详情
标题
Real life targeted therapies alone or in combination in brain metastases patients: French experience within MelBase
网址
求助人暂未提供
DOI
暂未提供,该求助的时间将会延长,查看原因?
其它 Melanoma brain metastases (BM) result in poor prognosis. Targeted therapies (TT) showed significant efficacy in monotherapy (Vemurafenib V/Dabrafenib D) and in combination (V+Cobimetinib VC/D+Trametinib DT). Encouraging data from BM treated by TT com-bination were reported. We present original results of efficacy and tol-erance in real life BM treated with TT (V/D, VC/DT) in French MelBase. It is a multicentric clinical biobank dedicated to prospective follow-up (FU) of unresectable stage III or IV melanoma adults. 1168 patients are included. Available data were collected (June 2017) and analyzed: monotherapy (gA), combination (gB). The characteristics are: gA (n = 58): mean age 58 years (48-70), PS 0-1 81%, LDH>ULN 36%, ≥3 metastatic organ sites (MOS) 60%, treated in 1st line 67%. gB (n = 64): mean age 56 years (45-64), PS 0-1 90%, LDH>ULN 39%, ≥3 MOS 63%, treated in 1st line 70%. After median FU 7.3 months (mos), median OS is 8.3 mos (95% CI:6.8-11.8;gA), 15.1 months (95% CI:7.7-NR;gB); median PFS is 4.0 mos (95% CI:3.5-5.6;gA), 6.6 mos (95% CI:5.5-8.1;gB). BORR is 31% (gA), 41% (gB); DCR is 64% (gA;gB). Age, LDH, PS, BM, radiotherapy (RT) were tested in univariate analysis. Multivariate analysis on global population (with treatment stratification) indicates that LDH (adjusted HR 1.9, 95% CI: 1.2-3.3), PS (aHR 3.6, 95% CI: 1.9-6.8), RT (aHR 2.3, 95% CI: 1.3-4.2) are significantly associated with OS; PS (aHR 3.0, 95% CI: 1.6-5.5), BM (aHR 1.5, 95% CI: 1.0-2.4) are significantly associated with PFS. OS and PFS seem similar to already published data (Davies 2017) in both groups. Adding anti-MEK increases BORR but not DCR. It increases PFS and OS but less than in patients without BM. It is the 1st study evaluating prognostic factors and pointing out RT as a good factor in multivariate analysis. Concomitant stereotaxic RT should systematically be discussed in BM patients treated by TT.
求助人
不吃早饭的猪猪子 在 2020-09-18 17:45:38 发布,悬赏 10 积分
下载
求助 / 应助时间线
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
FashionBoy应助HJCKYCG采纳,获得10
2秒前
科研菜鸟完成签到,获得积分10
2秒前
zzzhang驳回了Akim应助
3秒前
4秒前
6秒前
Hello应助悦动采纳,获得10
6秒前
又又发布了新的文献求助10
6秒前
我有一个博士梦完成签到 ,获得积分10
8秒前
9秒前
9秒前
贪玩丹秋完成签到,获得积分10
9秒前
wang12发布了新的文献求助10
9秒前
zsq发布了新的文献求助10
9秒前
11秒前
所所应助李Li采纳,获得10
11秒前
Woshikeyandawang完成签到,获得积分10
12秒前
山与月齐发布了新的文献求助10
13秒前
13秒前
孙鑫发布了新的文献求助10
13秒前
体贴薯片完成签到,获得积分10
14秒前
15秒前
15秒前
樱桃猴子应助加菲丰丰采纳,获得10
15秒前
16秒前
meimhuang完成签到,获得积分10
17秒前
落叶无悔发布了新的文献求助10
17秒前
17秒前
万能图书馆应助hsing采纳,获得10
18秒前
悦动发布了新的文献求助10
19秒前
19秒前
俏皮的山菡完成签到,获得积分10
19秒前
20秒前
董炳垚发布了新的文献求助10
21秒前
21秒前
乐观碧彤完成签到,获得积分10
22秒前
益生益生发布了新的文献求助10
22秒前
22秒前
机智ss完成签到,获得积分10
23秒前
高分求助中
Evolution 10000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Distribution Dependent Stochastic Differential Equations 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3157989
求助须知:如何正确求助?哪些是违规求助? 2809366
关于积分的说明 7881582
捐赠科研通 2467822
什么是DOI,文献DOI怎么找? 1313728
科研通“疑难数据库(出版商)”最低求助积分说明 630522
版权声明 601943